124 related articles for article (PubMed ID: 9544743)
1. Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells.
Kihara S; Ouchi N; Funahashi T; Shinohara E; Tamura R; Yamashita S; Matsuzawa Y
Atherosclerosis; 1998 Jan; 136(1):163-8. PubMed ID: 9544743
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone inhibits alpha1-adrenoceptor-induced DNA synthesis in vascular smooth muscle cells.
Nishio E; Watanabe Y
Eur J Pharmacol; 1999 Jun; 374(1):127-35. PubMed ID: 10422649
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
Law RE; Meehan WP; Xi XP; Graf K; Wuthrich DA; Coats W; Faxon D; Hsueh WA
J Clin Invest; 1996 Oct; 98(8):1897-905. PubMed ID: 8878442
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells.
Yasunari K; Kohno M; Kano H; Yokokawa K; Minami M; Yoshikawa J
Circ Res; 1997 Dec; 81(6):953-62. PubMed ID: 9400375
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.
Fukuda N; Hu WY; Teng J; Chikara S; Nakayama M; Kishioka H; Kanmatsuse K
Atherosclerosis; 2002 Aug; 163(2):229-39. PubMed ID: 12052469
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone improves blood flow by inhibiting neointimal formation after balloon injury in Otsuka Long-Evans Tokushima fatty rats.
Min KM; Park SW; Cho KY; Song MS; Kim DK; Park GS; Lee MK
Metabolism; 2002 Aug; 51(8):998-1002. PubMed ID: 12145772
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells.
Goetze S; Xi XP; Graf K; Fleck E; Hsueh WA; Law RE
FEBS Lett; 1999 Jun; 452(3):277-82. PubMed ID: 10386606
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells.
de Dios ST; Hannan KM; Dilley RJ; Hill MA; Little PJ
J Diabetes Complications; 2001; 15(3):120-7. PubMed ID: 11358680
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells.
Graf K; Xi XP; Hsueh WA; Law RE
FEBS Lett; 1997 Jan; 400(1):119-21. PubMed ID: 9000525
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.
Gouni-Berthold I; Berthold HK; Weber AA; Seul C; Vetter H; Sachinidis A
Exp Clin Endocrinol Diabetes; 2001; 109(4):203-9. PubMed ID: 11453032
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
13. Synergistic actions of insulin and troglitazone on contractility in endothelium-denuded rat aortic rings.
Goud C; Pitt B; Webb RC; Richey JM
Am J Physiol; 1998 Nov; 275(5):E882-7. PubMed ID: 9815009
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.
Tafuri SR
Endocrinology; 1996 Nov; 137(11):4706-12. PubMed ID: 8895337
[TBL] [Abstract][Full Text] [Related]
15. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
16. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
Okuno A; Ikeda K; Shiota M; Fujiwara T; Yoshioka S; Sugano T; Horikoshi H
Metabolism; 1997 Jun; 46(6):716-21. PubMed ID: 9186311
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.
Asano M; Nakajima T; Iwasawa K; Morita T; Nakamura F; Imuta H; Chisaki K; Yamada N; Omata M; Okuda Y
Br J Pharmacol; 1999 Oct; 128(3):673-83. PubMed ID: 10516648
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.
Chen Z; Ishibashi S; Perrey S; Osuga Ji ; Gotoda T; Kitamine T; Tamura Y; Okazaki H; Yahagi N; Iizuka Y; Shionoiri F; Ohashi K; Harada K; Shimano H; Nagai R; Yamada N
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):372-7. PubMed ID: 11231916
[TBL] [Abstract][Full Text] [Related]
19. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
[TBL] [Abstract][Full Text] [Related]
20. Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents.
Ciaraldi TP; Huber-Knudsen K; Hickman M; Olefsky JM
Metabolism; 1995 Aug; 44(8):976-81. PubMed ID: 7637655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
